Medexus Pharmaceuticals (MEDXF) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free MEDXF Stock Alerts $1.35 +0.05 (+3.85%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMedexus Pharmaceuticals (OTCMKTS:MEDXF) Trading 7% Higher americanbankingnews.com - April 25 at 1:48 AMMDP:CA Medexus Pharmaceuticals Inc.seekingalpha.com - April 3 at 1:58 PMMedexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Slashed Next Year's Estimatesfinance.yahoo.com - February 12 at 8:48 AMMedexus Pharmaceuticals Inc.wsj.com - February 9 at 1:28 PMMedexus Pharmaceuticals just downgraded at Raymond James, here's whyrealmoney.thestreet.com - February 9 at 1:28 PMMedexus Announces Fiscal Q3 2024 Resultsfinance.yahoo.com - February 7 at 6:57 PMHealth Canada Accepts for Review Medexus's New Drug Submission for Topical Terbinafinefinance.yahoo.com - January 8 at 9:22 AMMEDXF Medexus Pharmaceuticals Inc.seekingalpha.com - November 18 at 7:39 PMMedexus Pharmaceuticals reports Q2 resultsmsn.com - November 8 at 8:08 PMMedexus Fully Repays Convertible Debentures In Cash At Maturityfinance.yahoo.com - October 16 at 8:08 AMMedexus and medac Agree to Amend US Treosulfan Agreementfinance.yahoo.com - September 28 at 8:38 PMMedexus Holds Annual Meeting of Shareholders and Announces Election of Directorsfinance.yahoo.com - September 21 at 6:08 PMMedexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Unitsfinance.yahoo.com - September 5 at 8:35 PMMedexus Pharmaceuticals Inc (MDP) Receives a Buy from Stifel Nicolausmarkets.businessinsider.com - September 5 at 3:34 PMMedexus Strengthens Balance Sheet with US$18 Million Commitment Under Accordion Facilityfinance.yahoo.com - September 5 at 8:55 AMMedexus Study Supports Efficacy and Safety of IXINITY in Pediatric Patients with Severe or Moderately Severe Hemophilia Bfinance.yahoo.com - August 17 at 8:55 PMMedexus Announces Strong Fiscal Q1 2024 Results, Including Record Quarterly Revenue of US$31.6 Millionfinance.yahoo.com - August 9 at 5:46 PMMedexus Pharmaceuticals (MEDXF) Price Target Increased by 8.32% to 2.73msn.com - August 2 at 7:22 AMMedexus Schedules First Fiscal Quarter 2024 Conference Callfinance.yahoo.com - August 2 at 7:22 AMMedexus Announces Preliminary Revenue for Fiscal Q1 2024finance.yahoo.com - July 12 at 5:49 PMFDA Accepts for Review Medexus's IXINITY Supplemental Biological License Application for Pediatric Patientsfinance.yahoo.com - June 15 at 9:50 AMMedexus Schedules Fourth Fiscal Quarter and Fiscal Year 2023 Conference Callfinance.yahoo.com - June 14 at 6:17 PMMedexus to Participate in the LD Micro Invitational XIIIfinance.yahoo.com - June 1 at 9:01 PMMedexus Pharmaceuticals Inc.: Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debenturesfinanznachrichten.de - May 10 at 5:46 PMMedexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debenturesfinance.yahoo.com - May 10 at 5:46 PMMedexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Updatefinance.yahoo.com - April 11 at 9:09 AMMedexus Announces New License Deal for Topical Terbinafinefinance.yahoo.com - March 22 at 8:10 AMMedexus to Participate in 35th Annual Roth Conferencefinance.yahoo.com - March 6 at 8:07 AMMedexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022finance.yahoo.com - February 8 at 6:20 PMMedexus Secures Public Reimbursement for Cuvposa® in Quebecfinance.yahoo.com - February 1 at 6:57 PMMedexus Pharmaceuticals Inc: Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Updatefinanznachrichten.de - January 12 at 1:36 PMMedexus Pharmaceuticals FQ3 revenue to increase 34% Y/Ymsn.com - January 12 at 8:04 AMMedexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Updatefinance.yahoo.com - January 12 at 8:04 AMMedexus Schedules Second Quarter 2023 Conference Callfinance.yahoo.com - November 2 at 3:14 PMMedexus and MidCap Agree to Increase in MidCap's Revolving Loan Commitment Amountmarketwatch.com - October 2 at 12:45 AMMedexus Pharma Says FDA Requests More Information for Treosulfan Drug Applicationmarketwatch.com - September 19 at 10:40 AMMedexus Pharma Resubmits Treosulfan NDA To FDAmarkets.businessinsider.com - July 25 at 11:45 AMMedexus Generates Revenue of US$76.7 Million in Fiscal Year 2022 and US$20.3 million in Fiscal Q4 (Strongest Q4 Revenue in Company History)finance.yahoo.com - June 22 at 6:47 PMMedexus Pharmaceuticals (OTC:MEDXF), Short Interest Reportbenzinga.com - June 10 at 6:38 PMMedexus Pharmaceuticals (OTC:MEDXF), Earnings Estimates, EPS, and Revenuebenzinga.com - June 10 at 9:11 AMAnalysts Expect Breakeven For Medexus Pharmaceuticals Inc. (TSE:MDP) Before Longfinance.yahoo.com - May 9 at 9:28 AMMedexus, medac refile seeking FDA nod for Treosulfan in cancer patients undergoing stem-cell transplantseekingalpha.com - April 22 at 10:23 AMMedexus Pharmaceuticals Announces Resubmission of Treosulfan NDAfinance.yahoo.com - April 22 at 10:23 AMMedexus to Present at the Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 19 at 6:34 PMMedexus Pharmaceuticals reports FQ3 resultsseekingalpha.com - February 10 at 4:39 AMMedexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021finance.yahoo.com - February 9 at 6:38 PMMedexus to Present at the H.C. Wainwright BioConnect 2022 Conferencefinance.yahoo.com - January 7 at 10:02 AMMedexus to Present at the Q4 Investor Summit on November 17thfinance.yahoo.com - November 10 at 9:14 AMMedexus Pharmaceuticals Announces Appointment of Internal Counselfinance.yahoo.com - November 8 at 12:00 PMMedexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan | Morningstarmorningstar.com - November 3 at 1:27 AM Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDXF and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy MEDXF Media Mentions By Week MEDXF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEDXF News Sentiment▼-0.500.37▲Average Medical News Sentiment MEDXF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEDXF Articles This Week▼20▲MEDXF Articles Average Week Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News FFNTF News ABSCF News ACRDF News ACRHF News ALEAF News LBTSF News AZFL News ERBB News AVTBF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MEDXF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
